← Open Payments lookup

SANTOSH MAHARJAN: Open Payments

NPI 1073751616 · WARSAW, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$312 in 14 payments from 6 companies in 2025. Trend: 2023 $642 · 2024 $372 · 2025 $312

Food & beverage: $312
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.6$143
E.R. Squibb & Sons, L.L.C.3$57
Alkermes, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$27
Axsome Therapeutics, Inc.1$24
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: ABILIFY ASIMTUFII, COBENFY, ARISTADA, ABILIFY MAINTENA, REXULTI, CAPLYTA, Auvelity, TRINTELLIX.

Industry payments across IN — which companies pay providers there.